AIM ImmunoTech (AIM) Issues Letter to Stockholders

Go back to AIM ImmunoTech (AIM) Issues Letter to Stockholders

AIM ImmunoTech Issues Letter to Stockholders

March 6, 2023 8:45 AM UTC

Year marked by noteworthy operational execution and clinical development progress across pipeline

Company reiterates commitment to continued communication and activity with the investment and scientific communities

Poised to achieve multiple clinical and regulatory value-driving milestones in 2023

OCALA, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (AIM or the... More